SMAIO Philippe Roussouly

"Dear Madam, Dear Sir, 

The year 2023 marked a major turning point in SMAIO's history with the achievement of our 3 main objectives. First of all, the FDA's 510(k) certification of the customized version of our surgical planning software enabled us to receive a $3 million payment from our American partner, NuVasive. This demonstrates our expertise and paves the way for the upcoming release of a brand-new surgical planning platform incorporating artificial intelligence to model the spine and provide practitioners with an optimized simulation of the surgical outcomes to be achieved. In the second part of the year, we activated several major user centers of SMAIO solutions in the US, demonstrating the increasing adoption of our technology by surgeons and validating the relevance of the various training programs we have conducted in the US over the past months. Finally, we have strengthened our financial structure through non-dilutive funding of €2.5 million, providing us with the necessary resources to continue deploying our growth strategy focused on the North American market.”

Philippe ROUSSOULY
Chairman and CEO